Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 1442-1448, 2021.
Article in Chinese | WPRIM | ID: wpr-881279

ABSTRACT

OBJECTIVE:To ex plore the protective effects of Longbie capsule contained serum (called“LBJN”for short )on the apoptosis of chondrocytes induced by YAP inhibitor verteporfin and its mechanism. METHODS :Primary human knee osteoarthritis(OA)chondrocytes were extracted by two-step enzymatic digestion ,and then identif ied by toluidine blue staining and type Ⅱ collagen immunofluorescence staining. The effects of 2,5 μmol/L verteporfin alone or combined with 5%LBJN on cell apoptosis were detected by flow cytometry. Solvent control (0.1% DMSO)and 5% LBJN were set. Western blot assay was adopted to detect the expression of apoptosis related proteins (YAP,Bcl-2,cleaved-caspase-3) after treated with 0.1%DMSO(solvent control ),2 μmol/L verteporfin,2 μmol/L verteporfin+5%LBJN 和 0(blank control ),2.5% LBJN and 5% LBJN for 48 h. The expression of autophagy related proteins (mTOR,Beclin-1,LC3A/B) after treated with 0 (blank control ),2.5%,5% LBJN for 48 h were det ected by Western blot assay. RESULTS :The isolated cells accorded with the characteristics of chondrocytes. Compared with 0.1%DMSO, the apoptosis rates of cells were increased significantly after treated with 2,5 μmol/L verteporfin(P<0.05),and the effects of the two concentrations were similar (P>0.05). Compared with verteporfin alone ,2,5 μmol/L verteporfin combined with 5%LBJN could significantly decrease the apoptotic rate of cells (P<0.05). Compared with 0.1%DMSO,the protein expression of YAP and Bcl-2 were decreased significantly after treated with 2 μ mol/L verteporfin (P<0.05), while the protein expression of cleaved-caspase-3 were increased significantly (P<0.05). Compared with 2 μmol/L verteporfin,protein expression of YAP and Bcl-2 were increased significantly after treated with 2 μmol/L verteporfin+5%LBJN(P<0.05),while the protein expression of cleaved-caspase-3 were decreased significantly (P<0.05). Compared with blank control ,the protein expression of YAP ,Bcl-2 and Beclin-1 were increased significantly after treated with 2.5%,5%LBJN(P<0.05),while protein expression of cleaved-caspase- 3 and mTOR were decreased significantly (P<0.05). CONCLUSIONS :LBJN can block the apoptosis of chondrocytes induced by YAP inhibitor verteporfin ,and its mechanism may be related to regulating the expression of apoptosis related proteins and enhancing autophagy of chondrocytes.

2.
Chinese Journal of Tissue Engineering Research ; (53): 962-967, 2020.
Article in Chinese | WPRIM | ID: wpr-847892

ABSTRACT

BACKGROUND: Total hip arthroplasty with femoral neck prosthesis is being accepted by more and more doctors, but the effect of femoral neck prosthesis preservation or not on total hip arthroplasty is still uncertain. OBJECTIVE: To systematically evaluate the efficacy and safety of collum femoris preserving prosthesis in total hip arthroplasty. METHODS: CBM, CNKI, VIP, WanFang, PubMed, Embase and The Cochrane Library databases were searched systematically. The deadline was March 1,2018. All clinical controlled trials collum femoris preserving prosthesis in total hip arthroplasty were collected and methodological quality was evaluated one by one. RevMan 4.2 software was used for systematic evaluation. RESULTS AND CONCLUSION: (1) Four studies were included, involoing 302 patients. Because there were few studies and patients involved, and the outcome evaluation indicators were quite different, meta-analysis cannot be conducted, only descriptive systematic evaluation was performed. (2) Three studies compared the efficacy of two surgical methods in improving Harris score. Two of them considered that total hip arthroplasty with collum femoris preserving prosthesis was significantly better than total hip arthroplasty with non-collum femoris preserving prosthesis (P 0.05). (3) Two studies compared the efficacy of two surgical methods in improving the range of motion of the joint. One study showed that total hip arthroplasty with collum femoris preserving prosthesis was significantly better than total hip arthroplasty with non-prosthesis (P 0.05). (4) One study showed that bone loss around the prosthesis in the total hip arthroplasty group with prosthesis was significantly less than that in the total hip arthroplasty group without collum femoris preserving prosthesis at 1 year postoperatively (P 0.05). (8) One study found that the total amount of bleeding in total hip arthroplasty group with collum femoris preserving prosthesis was higher than that in total hip arthroplasty group without collum femoris preserving prosthesis (P < 0.05). (9) In summary, total hip arthroplasty with collum femoris preserving prosthesis has advantages in improving Harris score, decreasing the Visual Analogue Scale score and that bone loss around the prosthesis. More rigorous research is needed to increase the intensity of evidence.

3.
China Pharmacy ; (12): 448-453, 2019.
Article in Chinese | WPRIM | ID: wpr-817085

ABSTRACT

OBJECTIVE: To study the effects of ligustrazine on miR-20b/VEGF and BMP2/Smad1 pathways in subchondral bone of knee osteoarthritis (KOA) model rats, and to investigate the mechanism of ligustrazine for KOA prevention and treatment. METHODS: Totally 18 healthy male SD rats were randomly divided into normal control group, model group and ligustrazine group, with 6 rats in each group. The rats in the latter two groups were used to establish KOA model by intra-articular injection of 4% papain solution. From the 2nd day after the last injection, ligustrazine group was given intragastrical administration of Ligustrazine suspension (100 mg/kg) 2 mL; normal control group and model group were given intragastrical administration of isometrical normal saline, once a day, for consecutive 6 weeks. After the last after medication, the situation of bilateral knee articular cartilage of rats were observed after exposure. The knee joints of rats were sectioned and stained with HE. The pathological change of articular cartilage were observed by microscope and scored by modified Mankin’s score. mRNA expression of VEGF, BMP2 and Smad1, and the expression of miR-20b were detected by RT-PCR; the protein expression of VEGF, BMP2 and Smad1 were detected by Western blot assay. RESULTS: Model group and ligustrazine group suffered from cartilage injury of knee joint at varying degrees. Compared with normal control group, Mankin’s scores of knee joint and cartilage tissue were increased significantly in model group (P<0.01); mRNA and protein expression of BMP and Smad1, the expression of miR-20b in subchondral bone of model group were decreased significantly, while mRNA and protein expression of VEGF were increased significantly (P<0.01). Compared with model group, Mankin’s score of cartilage tissue were decreased significantly in ligustrazine group (P<0.01); mRNA and protein expression of BMP and Smad1, the expression of miR-20b in subchondral bone were increased significantly, while mRNA and protein expression of VEGF were decreased significantly (P<0.05 or P<0.01). CONCLUSIONS: Ligustrazine can repair damaged articular cartilage in KOA model rats, the mechanism of which may be associated with inhibiting the protein expression of VEGF and activating BMP-2/Smad1 signaling pathway via up-regulating the expression of miR-20b, and promoting the degradation of VEGF mRNA in subchondral bone.

SELECTION OF CITATIONS
SEARCH DETAIL